Emeritus agrees to be acquired by Brookdale Senior Living; Wal-Mart to spend more than $200M on investigations in the next fiscal year


Follow this company

Companies Mentioned

NASDAQ:ESC / NASDAQ:ARUN / NASDAQ:INO / NYSE:WMT
02/24/2014 [ACCESSWIRE]

Wondering what your next move should be in the market? BullTrends.com can help lead the way. For free access to our complete stock reports, take a few minutes to register with us by clicking this link: http://www.bulltrends.com/ 

Emeritus Corp. (NYSE: ESC) – For an in-depth report on Emeritus Corp. follow: www.BullTrends.com/stockquote/ESC

Shares of Emeritus Corp closed up 35.18% on Friday with about 15.7 million shares traded. The stock was one of the biggest winners on the NYSE. The senior housing operator saw a big move up after agreeing to be acquired by Brookdale Senior Living for $1.4 billion, excluding debt. Under the terms of the deal, Emeritus shareholders will receive 0.95 shares of Brookdale, and would effectively own 23% of the outstanding shares of the company once the merger is complete. Brookdale anticipates the deal being EPS neutral in 2014, and forecasts it adding $0.40 in EPS by the third year.

Aruba Networks, Inc. (NASDAQ: ARUN) – For an in-depth report on Aruba Networks, Inc. follow: www.BullTrends.com/stockquote/ARUN

Aruba Networks closed down 1.71% this past Friday with over 10 million shares traded. The stock soared higher after beating estimates on second-quarter sales and earnings. Year to date, the stock has climbed 24.6%. In the three months to December, the company recorded net income of 18 cents a share and sales of $176.4 million. Analysts surveyed by Thomson Reuters had anticipated per-share earnings of 17 cents a share and revenue of $167.57 million.

Inovio Pharmaceuticals, Inc. (NYSE: INO) – For an in-depth report on Inovio Pharmaceuticals, Inc. follow: www.BullTrends.com/stockquote/INO

Inovio Pharmaceuticals closed up 11.03% on Friday with about 20.6 million shares traded. The stock was one of the most active stocks in the NYSE and even hit a new one-year high of $3.24 during intra-day trading. The company’s VGX-3100 targets moderate to severe-stage cervical dysplasia (which in rare cases is a precursor to cervical cancer) associated with HPV strains 16 and 18 in an ongoing Phase 2 study slated to read out by Q2 2014. The Company was most recently valued at just under $600 Million.

Wal-Mart Stores Inc. (NYSE: WMT) – For an in-depth report on Wal-Mart Stores Inc. Corporation follow: www.BullTrends.com/stockquote/WMT

Wal-Mart closed down a modest 0.54% on Friday with nearly 9 million shares traded. The stock was one of the most active stocks in the NYSE after the company announced on Thursday that it expects to spend more than $200 million in the next fiscal year on investigations related to potential foreign bribery violations. The company posted earnings last Thursday for the final quarter of its fiscal 2014, which ended Jan. 31, and said in its statement that it anticipates expenses for compliance enhancements and issues relating to the investigation to “range between $200 and $240 million” in fiscal 2015.

 

Wondering what your next move should be in the market? BullTrends.com can help lead the way. For free access to our complete stock reports, take a few minutes to register with us by clicking this link: http://www.bulltrends.com/

 

Disclosure: BullTrends.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please read our report and visit our website, for complete risks and disclosures.

COMMENTS

Leave a comment...
 * 

Your Name
 *